Alexandra Chapdelaine

Sociodemographic factors and beliefs about medicines in the uptake of pharmacogenomic testing in older adults.

T. Poder, C. Lamoureux-Lamarche, H. Vasiliadis, 2021, Pharmacogenomics.

Treatment adequacy for social anxiety disorder in primary care patients

A. Duhoux, L. Fournier, P. Roberge, 2018, PloS one.

Moderators of the cost-effectiveness of transdiagnostic CBT for anxiety disorders over an 8-month time horizon using a net-benefit regression framework

H. Vasiliadis, P. Roberge, M. Provencher, 2023, BMC Health Services Research.

Cost-effectiveness of transdiagnostic group cognitive behavioural therapy for anxiety disorders v. treatment as usual: economic evaluation of a pragmatic randomized controlled trial over an 8-month time horizon using self-reported data

H. Vasiliadis, P. Roberge, M. Provencher, 2023, Psychological Medicine.

Cost-Effectiveness of Group Transdiagnostic Cognitive Behavioural Therapy for Anxiety Disorders in Primary Care Settings: Economic Evaluation From the Healthcare System Perspective Over a 1-Year Time Horizon.

D. Berbiche, C. Lamoureux-Lamarche, H. Vasiliadis, 2023, Canadian journal of psychiatry. Revue canadienne de psychiatrie.